![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Clinical Trials
Lilly Begins World’s First Study of a Potential COVID-19 Antibody Treatment in Humans
Eli Lilly and Company announced patients have been dosed in the world's first study of a potential antibody treatment designed to fight COVID-19.
This investigational...
Clinical Trials
LabCorp Accelerates Adoption of Decentralized Clinical Trials, Expands Technology Ecosystem Through Alliance With Medable
LabCorp, a leading global life sciences company that is deeply integrated in guiding patient care, announced that Covance, its drug development business, is expanding...
Clinical Trials
Roche’s Port Delivery System with ranibizumab shows positive phase III results in neovascular age-related macular degeneration
Roche announced positive topline results from the phase III Archway study, evaluating Port Delivery System with ranibizumab (PDS) in people living with neovascular or...
Clinical Trials
Novavax Initiates Phase 1/2 Clinical Trial of COVID-19 Vaccine
Novavax, Inc. , a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, announced enrollment of the first participants in a Phase 1/2...
Clinical Trials
Glenmark to Combine Two Anti-Viral Drugs; Start Trials on Indian COVID-19 Patients
Glenmark Pharmaceuticals announced on Tuesday that it will commence another new Phase 3 clinical trial on a combination of two anti-viral drugs Favipiravir and...
Clinical Trials
AstraZeneca collaborates with ArcherDX to use personalised cancer assays to detect minimal residual disease in lung cancer trials
AstraZeneca will collaborate with ArcherDX, a genomic analysis company focused on precision oncology, to use personalised cancer monitoring to detect minimal residual disease (MRD)...
Articles
Rethinking Travel as Part of a Good Patient-Centric Clinical Trial
The landscape for clinical trials has seemingly been turned upside down with the onset of the COVID-19 pandemic. However, there is one factor that...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read